Century Therapeutics, Inc. (IPSC) Operating income 2020–2025
Century Therapeutics, Inc. (IPSC) annual operating income history from SEC filings — each fiscal year as reported.
-$17.3MFY2025 · since FY2020: -$53.9M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +87.5% |
| FY2024 | -$138.1M | +5.7% |
| FY2023 | -$146.5M | -9.5% |
| FY2022 | -$133.8M | -41.0% |
| FY2021 | -$94.9M | -76.0% |
| FY2020 | -$53.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice